Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Barry

Showing results (181-190 of 1,132) with videos related to

Pageof 114
Sort By:
The New England Journal of Medicine|August 19, 2011
Moving beyond parity--mental health and addiction care under the ACAColleen L Barry, Haiden A Huskamp
Journal of Clinical Microbiology|March 1, 1990
Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing GroupA L Barry, R N Jones
The Journal of Antimicrobial Chemotherapy|August 1, 1995
BO-2727, meropenem and imipenem disc diffusion susceptibility testing criteriaA L Barry, P C Fuchs
Journal of Clinical Microbiology|July 1, 1989
Comparison of cefadroxil and cephalothin disk susceptibility test resultsA L Barry, R N Jones
The New England Journal of Medicine|April 4, 2020
Stigma Reduction to Combat the Addiction Crisis - Developing an Evidence BaseEmma E McGinty, Colleen L Barry
Journal of Clinical Microbiology|October 1, 1987
Reliability of high-content disks and modified broth dilution tests for detecting staphylococcal resistance to the penicillinase-resistant penicillinsA L Barry, R N Jones
European Journal of Clinical Microbiology|April 1, 1987
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility testA L Barry, R N Jones
Journal of Clinical Microbiology|November 1, 1987
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporinR N Jones, A L Barry
The Journal of Physiology|May 1, 1973
A new method for demonstrating oxygen-haemoglobin dissociation curvesW L Barry, V A Knight
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830)R N Jones, A L Barry
Pageof 114

Showing results (181-190 of 1,132) with videos related to

Sort By:
Pageof 114
The New England Journal of Medicine|August 19, 2011
Moving beyond parity--mental health and addiction care under the ACAColleen L Barry, Haiden A Huskamp
Journal of Clinical Microbiology|March 1, 1990
Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing GroupA L Barry, R N Jones
The Journal of Antimicrobial Chemotherapy|August 1, 1995
BO-2727, meropenem and imipenem disc diffusion susceptibility testing criteriaA L Barry, P C Fuchs
Journal of Clinical Microbiology|July 1, 1989
Comparison of cefadroxil and cephalothin disk susceptibility test resultsA L Barry, R N Jones
The New England Journal of Medicine|April 4, 2020
Stigma Reduction to Combat the Addiction Crisis - Developing an Evidence BaseEmma E McGinty, Colleen L Barry
Journal of Clinical Microbiology|October 1, 1987
Reliability of high-content disks and modified broth dilution tests for detecting staphylococcal resistance to the penicillinase-resistant penicillinsA L Barry, R N Jones
European Journal of Clinical Microbiology|April 1, 1987
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility testA L Barry, R N Jones
Journal of Clinical Microbiology|November 1, 1987
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporinR N Jones, A L Barry
The Journal of Physiology|May 1, 1973
A new method for demonstrating oxygen-haemoglobin dissociation curvesW L Barry, V A Knight
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830)R N Jones, A L Barry
Pageof 114